BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24641480)

  • 21. The overlap of skin and blood T-cell clones in early-stage mycosis fungoides.
    Joffe D; Bhatti S; Banner L; Zaya R; Gleason L; Mishra A; Kirsch I; Porcu P; Nikbakht N
    Blood Adv; 2023 Oct; 7(20):6206-6210. PubMed ID: 37611154
    [No Abstract]   [Full Text] [Related]  

  • 22. Psoriasiform mycosis fungoides: a clinical and prognostic retrospective cohort study.
    Jung JM; Cho HS; Kim GH; Won CH; Chang SE; Park CS; Lee MW; Lee WJ
    Br J Dermatol; 2024 Feb; 190(3):432-434. PubMed ID: 37936328
    [No Abstract]   [Full Text] [Related]  

  • 23. Line-field confocal optical coherence tomography: A new in vivo assessment tool for cutaneous mycosis fungoides.
    Soglia S; Pérez-Anker J; Ghini I; Lenoir C; Maione V; Sala R; Tonon F; Suppa M; Calzavara-Pinton PG; Malvehy J; Venturini M
    J Eur Acad Dermatol Venereol; 2024 Mar; 38(3):e296-e298. PubMed ID: 37983937
    [No Abstract]   [Full Text] [Related]  

  • 24. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.
    Scarisbrick JJ; Prince HM; Vermeer MH; Quaglino P; Horwitz S; Porcu P; Stadler R; Wood GS; Beylot-Barry M; Pham-Ledard A; Foss F; Girardi M; Bagot M; Michel L; Battistella M; Guitart J; Kuzel TM; Martinez-Escala ME; Estrach T; Papadavid E; Antoniou C; Rigopoulos D; Nikolaou V; Sugaya M; Miyagaki T; Gniadecki R; Sanches JA; Cury-Martins J; Miyashiro D; Servitje O; Muniesa C; Berti E; Onida F; Corti L; Hodak E; Amitay-Laish I; Ortiz-Romero PL; Rodríguez-Peralto JL; Knobler R; Porkert S; Bauer W; Pimpinelli N; Grandi V; Cowan R; Rook A; Kim E; Pileri A; Patrizi A; Pujol RM; Wong H; Tyler K; Stranzenbach R; Querfeld C; Fava P; Maule M; Willemze R; Evison F; Morris S; Twigger R; Talpur R; Kim J; Ognibene G; Li S; Tavallaee M; Hoppe RT; Duvic M; Whittaker SJ; Kim YH
    J Clin Oncol; 2015 Nov; 33(32):3766-73. PubMed ID: 26438120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.
    Hughes CF; Newland K; McCormack C; Lade S; Prince HM
    Australas J Dermatol; 2016 Aug; 57(3):182-91. PubMed ID: 25988337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
    Trautinger F; Eder J; Assaf C; Bagot M; Cozzio A; Dummer R; Gniadecki R; Klemke CD; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Whittaker S; Willemze R; Knobler R
    Eur J Cancer; 2017 May; 77():57-74. PubMed ID: 28365528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome.
    Photiou L; van der Weyden C; McCormack C; Miles Prince H
    Curr Oncol Rep; 2018 Mar; 20(4):32. PubMed ID: 29572582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced-stage mycosis fungoides and Sézary syndrome: survival and response to treatment.
    Alberti-Violetti S; Talpur R; Schlichte M; Sui D; Duvic M
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e105-12. PubMed ID: 25817937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biomarker landscape in mycosis fungoides and Sézary syndrome.
    Dulmage B; Geskin L; Guitart J; Akilov OE
    Exp Dermatol; 2017 Aug; 26(8):668-676. PubMed ID: 27897325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2016 Jan; 91(1):151-65. PubMed ID: 26607183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.
    Berg S; Villasenor-Park J; Haun P; Kim EJ
    Curr Hematol Malig Rep; 2017 Jun; 12(3):234-243. PubMed ID: 28540671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous T cell Lymphoma: an Update on Pathogenesis and Systemic Therapy.
    Chung CG; Poligone B
    Curr Hematol Malig Rep; 2015 Dec; 10(4):468-76. PubMed ID: 26626770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
    Olsen EA
    Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2014 Aug; 89(8):837-51. PubMed ID: 25042790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review of combination therapies for mycosis fungoides.
    Humme D; Nast A; Erdmann R; Vandersee S; Beyer M
    Cancer Treat Rev; 2014 Sep; 40(8):927-33. PubMed ID: 24997678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.
    Wu PA; Huang V; Bigby ME
    Br J Dermatol; 2014 May; 170(5):1015-20. PubMed ID: 24841586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycosis Fungoides and Sézary Syndrome: An Update.
    Larocca C; Kupper T
    Hematol Oncol Clin North Am; 2019 Feb; 33(1):103-120. PubMed ID: 30497668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and prognostic factors for mycosis fungoides and Sézary syndrome in a multi-ethnic Asian cohort: a 12-year review.
    Lim HLJ; Tan EST; Tee SI; Ho ZY; Boey JJJ; Tan WP; Tang MBY; Shen L; Chan YH; Tan SH
    J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):1513-1521. PubMed ID: 30801779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy.
    Kamijo H; Miyagaki T
    Curr Treat Options Oncol; 2021 Jan; 22(2):10. PubMed ID: 33415447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
    Scarisbrick JJ; Quaglino P; Prince HM; Papadavid E; Hodak E; Bagot M; Servitje O; Berti E; Ortiz-Romero P; Stadler R; Patsatsi A; Knobler R; Guenova E; Child F; Whittaker S; Nikolaou V; Tomasini C; Amitay I; Prag Naveh H; Ram-Wolff C; Battistella M; Alberti-Violetti S; Stranzenbach R; Gargallo V; Muniesa C; Koletsa T; Jonak C; Porkert S; Mitteldorf C; Estrach T; Combalia A; Marschalko M; Csomor J; Szepesi A; Cozzio A; Dummer R; Pimpinelli N; Grandi V; Beylot-Barry M; Pham-Ledard A; Wobser M; Geissinger E; Wehkamp U; Weichenthal M; Cowan R; Parry E; Harris J; Wachsmuth R; Turner D; Bates A; Healy E; Trautinger F; Latzka J; Yoo J; Vydianath B; Amel-Kashipaz R; Marinos L; Oikonomidi A; Stratigos A; Vignon-Pennamen MD; Battistella M; Climent F; Gonzalez-Barca E; Georgiou E; Senetta R; Zinzani P; Vakeva L; Ranki A; Busschots AM; Hauben E; Bervoets A; Woei-A-Jin FJSH; Matin R; Collins G; Weatherhead S; Frew J; Bayne M; Dunnill G; McKay P; Arumainathan A; Azurdia R; Benstead K; Twigger R; Rieger K; Brown R; Sanches JA; Miyashiro D; Akilov O; McCann S; Sahi H; Damasco FM; Querfeld C; Folkes A; Bur C; Klemke CD; Enz P; Pujol R; Quint K; Geskin L; Hong E; Evison F; Vermeer M; Cerroni L; Kempf W; Kim Y; Willemze R
    Br J Dermatol; 2019 Aug; 181(2):350-357. PubMed ID: 30267549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.